Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

m6A epitranscriptomic regulation in acute myeloid leukemia: From leukemic dependencies to therapy resistance and therapeutic targeting.

Created on 19 Nov 2026

Authors

Chenchen Ma, Xin Wang, Wei Zheng, Longtao Yue, Jingyi Wang

Published in

Biochimica et biophysica acta. Reviews on cancer. Pages 189752. Nov 18, 2026. Epub Nov 18, 2026.

Abstract

N6-methyladenosine (m6A) RNA methylation has emerged as an important post-transcriptional regulatory mechanism in acute myeloid leukemia (AML). Dysregulated m6A writers, erasers and readers influence leukemic stem cell maintenance, myeloid differentiation, RNA stability, translation, metabolic adaptation and treatment response. This review summarizes current evidence, spanning expression associations, regulator-dependent phenotypes and site-specific m6A mechanisms, linking METTL3, METTL14, FTO, ALKBH5, YTHDF proteins and IGF2BP family members to AML biology and therapy resistance. We focus on chemotherapy, venetoclax, anthracycline and differentiation-therapy resistance, and on preclinical and early clinical agents targeting METTL3, FTO, ALKBH5 and selected readers. We also discuss limitations in current evidence, including context-dependent transcript regulation, incomplete distinction between catalytic m6A-dependent and non-catalytic regulator functions, correlative immune and pediatric prognostic associations, uncertain therapeutic windows, biomarker heterogeneity and challenges in measuring functionally relevant m6A changes in patient samples. These issues should be addressed before m6A-directed strategies can be incorporated into AML precision therapy.

PMID:
43051605
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement